Daily Investment Strategy

2026.03.09 09:00

Daily focus Real-Time Quote

JD.com(9618): revenue for the full year of 2025 reached RMB 1,309.1 billion, a year-on-year increase of 13.0%. However, profitability was significantly pressured, with net profit attributable to ordinary shareholders declining to RMB 19.6 billion from RMB 41.4 billion in 2024. Particularly in the fourth quarter, a significant increase in investment in new business strategies resulted in a net loss of RMB 2.7 billion, compared to a net profit of RMB 9.9 billion in the same period last year. Under non-GAAP accounting standards, net profit also shrank from RMB 47.8 billion to RMB 27 billion, reflecting the challenge of narrowing profits during the company's expansion. Looking ahead, management acknowledged that industry competition remains fierce and that the company will continue to improve operational efficiency through AI technology and steadily advance the official launch of overseas markets such as Joybuy in Europe. In summary, JD.com is in a strategic transformation period in 2025, attempting to strike a balance between the stability of its core business and the expansion of new businesses.

The "Support and Control measure" Monetary Policy Guidance

During the Two Sessions, People's Bank of China Governor Pan Gongsheng explicitly proposed a "support and control measure" monetary policy guidance, the core of which lies in precisely reshaping the industrial ecosystem through financial leverage. For strategic emerging industries and key projects of the 15th Five-Year Plan, the central bank will increase credit support; while for industries with overcapacity and vicious "involution," it will adopt a "control" approach, resolutely cutting off the funding chains of enterprises relying on low-price competition and loss-making expansion. This shift in macroeconomic strategy aims to release financial resources from inefficient production capacity and direct them towards leading enterprises with high technological barriers, essentially restoring industrial profit margins through supply-side financial reform. This not only effectively alleviates current deflationary concerns and boosts PPI levels but also reflects the policymakers' commitment to improving the quality of economic growth. Through this structural clearing, market expectations will improve the risk premium of Chinese assets, supporting the revaluation of high-quality leading stocks in the macroeconomic recovery path, laying a solid credit foundation for high-quality development in the next five years.

On Friday, Hong Kong Stock Connect saw a net outflow of HK$2.188 billion. Tencent Holdings (00700) saw the largest inflow at HK$2.26 billion, followed by Meituan-W (03690). Alibaba-W (09988) recorded the largest net outflow at HK$630 million, followed by SMIC (00981).

Recommended Stocks
Capture the moment and trade with KGI Asia's insights
Stocks
Recommended
Stocks
Recommended

Leung Kai Tong is a SFC licensed person accredited to KGI Group to carry on regulated activities (for details, please refer to https://apps.sfc.hk/publicregWeb/indi/ADU276/details). He and/or his associate do not have any financial interest in the recommended issuer or new listing applicant.

The materials contained herein are provided by KGI Asia Limited ("KGI") for information only. While such materials are based on or derived from sources believed to be reliable, KGI makes no representation or warranty (express or implied) as to their accuracy or reliability. Neither the information nor the opinions expressed herein constitute, or are to be construed as, an offer or invitation or solicitation of an offer to buy or sell any securities or investments. KGI and its officers, employees, agents and affiliates may have interests in the securities or investments covered herein and accept no liability whatsoever for any loss or consequence whatsoever (whether direct or indirect) resulting from any use of or reliance by you on such materials.

Subscribe to KGI Market Insights Reports
Outperform market and make the best investment decisions